Oramed Pharmaceuticals Inc. (ORMP)
$5.03
$-0.07
(-1.37%)
As on 28-Aug-2026 16:00EDT
Market cap
$206 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
1.2
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
2.1
-
Debt to Equity
0
-
Book Value
$7.7
-
EPS
$4.1
-
Face value
--
-
Shares outstanding
40,926,081
10 Years Aggregate
CFO
$-127.24 Mln
EBITDA
$-172.39 Mln
Net Profit
$-169.53 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Oramed Pharmaceuticals (ORMP)
| 76.5 | 20.9 | 26.4 | 127.6 | 15.8 | -23.1 | -4.1 |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Oramed Pharmaceuticals (ORMP)
| 17.8 | 4.7 | -80.8 | -15.8 | 236.8 | -17.7 | 71.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Oramed Pharmaceuticals (ORMP)
|
5.0 | 205.9 | 0.0 | 174.9 | -- | 67.6 | 1.2 | 0.7 |
| 84.9 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 247.9 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 72.1 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.5 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 105.4 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 351.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 533.8 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 600.7 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 344.8 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Oramed Pharmaceuticals (ORMP)
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical... trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York. Read more
-
President, CEO & Executive Chairman
Mr. Nadav Kidron Esq.
-
President, CEO & Executive Chairman
Mr. Nadav Kidron Esq.
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Oramed Pharmaceuticals (ORMP)
What is the current share price of Oramed Pharmaceuticals Inc (ORMP) Today?
The share price of Oramed Pharmaceuticals Inc (ORMP) is $5.03 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Oramed Pharmaceuticals Inc (ORMP) has given a return of 15.79% in the last 3 years.
What is the current PB & PE ratio of Oramed Pharmaceuticals Inc (ORMP)?
The P/E ratio of Oramed Pharmaceuticals Inc (ORMP) is 1.24 times as on 28-Aug-2026.
The P/B ratio of Oramed Pharmaceuticals Inc (ORMP) is 0.67 times as on 28-Aug-2026, a 87 discount to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
1.80 |
0.58 |
2024 |
-5.07 |
0.66 |
2023 |
16.88 |
0.57 |
2023 |
-- |
-- |
2022 |
-12.44 |
3.09 |
What is the 52 Week High and Low of Oramed Pharmaceuticals Inc (ORMP)?
The 52-week high and low of Oramed Pharmaceuticals Inc (ORMP) are Rs 5.47 and Rs 2.09 as of 30-Aug-2026.
What is the market cap of Oramed Pharmaceuticals Inc (ORMP)?
Oramed Pharmaceuticals Inc (ORMP) has a market capitalisation of $ 206 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Oramed Pharmaceuticals Inc (ORMP)?
Before investing in Oramed Pharmaceuticals Inc (ORMP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.